In 10 seconds? Scientists have been using an amazing technology called single-cell RNA sequencing to try to make sense of the different ways our immune system can interact with tumors. Why the need for interaction? In our Immunit...
In 10 seconds? Natural Killer cells are a type of immune cell that researchers are engineering to tackle blood cancers–which may cause fewer side effects than T cells. What’s the story? Our Immunity vs. Cancer series has dug into...
In 10 seconds? Scientists are using tons of ingenious methods to produce next-generation CAR-T cells that provide hope that this therapy may have improved success against solid tumors in the future. What’s the story? In our last...
In 10 seconds? Scientists have figured out how to use intricate cellular engineering to turn T-cells into enhanced cancer-killing machines–AKA CAR-T cells–that have been remarkably successful in treating multiple types of blood ca...
In 10 seconds? We continue our chat about cancer immune checkpoint therapies–which help our immune system attack cancer. One area showing progress is the quest for discrete biological features (AKA biomarkers) that indicate positi...
In 10 seconds? Immune checkpoint inhibitors are recently developed cancer immunotherapies that have helped treat advanced-stage cancers–such as skin and lung cancer. What’s the story? In our last Immunity vs Cancer digest, we lea...
In 10 seconds? Scientists have learned that a type of immune cell, called T cells, plays an important role in detecting and killing cancer cells, prompting the development of a slew of T cell-boosting cancer treatments. What’s th...
In 10 seconds? In this Immunity vs Cancer digest, we break down cancer inflammation and how steroids are used in cancer treatment. What’s the story? The role of steroids as a cancer treatment has surfaced in the news recently. So...
In 10 seconds? Did you know your immune system plays an important role in fighting cancer? In the first post of our newest series, Immunity vs Cancer, we will break down the biggest breakthroughs in cancer immunology–starting with...